Hyliion Holdings Corp
For the period ended Dec 31, 2023. Filed Feb 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 13, 2024
HYLN$2.99-4.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollar amounts in thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cash flows from operating activities | ||
| Net loss | $(123,510) | $(153,357) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,511 | 1,227 |
| Amortization and accretion of investments, net | (2,868) | 1,250 |
| Noncash lease expense | 1,496 | 1,244 |
| Inventory write-down | 1,139 | 5,641 |
| (Gain) loss on impairment and disposal of assets | (1) | 19 |
| Share-based compensation | 6,217 | 6,979 |
| Provision for doubtful accounts | — | 114 |
| Acquired in-process research and development (Note 2) | — | 28,752 |
| Change in operating assets and liabilities, net of effects of business acquisition: | ||
| Accounts receivable | 1,096 | (1,180) |
| Inventory | (1,065) | (5,601) |
| Prepaid expenses and other assets | 463 | (571) |
| Accounts payable | 1,356 | (4,660) |
| Accrued expenses and other liabilities | (3,020) | 4,571 |
| Operating lease liabilities | (1,776) | (1,305) |
| Net cash used in operating activities | (116,962) | (116,877) |
| Cash flows from investing activities | ||
| Purchase of property and equipment and other | (7,401) | (2,885) |
| Proceeds from sale of property and equipment | 2 | 152 |
| Purchase of in-process research and development | — | (14,428) |
| Payments for security deposit, net | (45) | — |
| Purchase of investments | (189,670) | (268,584) |
| Proceeds from sale and maturity of investments | 215,422 | 263,723 |
| Net cash provided by (used in) investing activities | 18,308 | (22,022) |
| Cash flows from financing activities | ||
| Proceeds from exercise of common stock options | 257 | 79 |
| Taxes paid related to net share settlement of equity awards | (239) | (157) |
| Repurchase of treasury stock | (33) | — |
| Net cash used in financing activities | (15) | (78) |
| Net decrease in cash and cash equivalents and restricted cash | (98,669) | (138,977) |
| Cash and cash equivalents and restricted cash, beginning of period | 120,133 | 259,110 |
| Cash and cash equivalents and restricted cash, end of period | $21,464 | $120,133 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.